Letter to Shareholders & Notice of GM & Proxy Form
Filed with ASX · · 39 pages · English
Earlier from TrivarX
- Phase 2 Trial Commences for SAMDE Study
- Proposed issue of securities - MEB
- Medibio Receives Firm Commitments to Raise $2.25m
- June 2023 Quarterly Activities Report and Appendix 4C
- Phase 1 Trial Completed for SAMDE Study
Later from TrivarX
- Board and Management Transition
- Phase 2 SAMDE Study Update
- December 2023 Quarterly Activities Report and Appendix 4C
- TRI-001 Algorithm and Phase 2 Trial Update
- TrivarX Receives $888k R&D Tax Incentive
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX